Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × Pico-Salax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1738 Radiotherapy 1598 Cisplatin 1530 Carboplatin 1298 Gemcitabine 1206 Paclitaxel 1102 Bevacizumab 1059 Docetaxel 1046 pembrolizumab 1024 Oxaliplatin 979 Capecitabine 979 Fluorouracil 915 Dexamethasone 830 Rituximab 779 Nivolumab 778 Magnetic Resonance Spectroscopy 729 Etoposide 705 Doxorubicin 699 Irinotecan 663 Radiosurgery 662 Drug Therapy 659 Cytarabine 636 fludarabine 619 Leucovorin 578 Lenalidomide 525 fludarabine phosphate 481 Radiation 467 Temozolomide 466 Filgrastim 463 Cetuximab 457

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05148494 2024-08-27

TESEO

Nova Scotia Health Authority

Phase 4 Recruiting

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡